Back to search

Article

Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance

2021-06-14

Abstract excerpt

Very high risk neuroblastoma is characterised by increased MAPK signalling, and targeting MAPK signalling is a promising therapeutic strategy. We used a deeply characterised panel of neuroblastoma cell lines and found that the sensitivity to MEK inhibitors varied drastically between these cell lines. By generating quantitative perturbation data and mathematical modelling, we determined potential resistance mechani...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ca282f89-f0c8-5ceb-af4e-60f8e287b6b7
DOI
10.1101/2021.06.14.448322
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistanceDOI 10.1101/2021.06.14.448322
Select a neighboring publication to make it the new centre.